Thanks, Jon, that's a very interesting list for those that are looking for new candidates. And thanks to ICE for highlighting some troubled names. I only follow the anticancers, and amongst those I would add Aptosyn as a suspect. FDA denied its NDA for colorectal polyps a year ago, and it is still up in the air whether their other cancer indications will turn out better.Cliff
Best Of |
Favorites & Replies |
Start a New Board |
My Fool |
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ra